Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 1,188 | 1,550 | 627 | 2,277 | 2,209 |
| Gross Profit | 1,188 | 1,550 | 627 | 2,277 | 2,209 |
| Operating Expenses | 29,629 | 24,784 | 27,079 | 24,690 | 32,286 |
| Operating Income | -28,441 | -23,234 | -26,452 | -22,413 | -30,077 |
| Interest Expense | 62 | 263 | 247 | 0 | 0 |
| Other Income | -1,621 | -94 | 482 | 127 | 258 |
| Pre-tax Income | -30,124 | -23,591 | -26,217 | -22,286 | -29,819 |
| Net Income Continuous | -30,124 | -23,591 | -26,217 | -22,286 | -29,819 |
| Net Income | $-30,124 | $-23,591 | $-26,217 | $-22,286 | $-29,819 |
| EPS Basic Total Ops | -0.82 | -0.80 | -0.97 | -0.85 | -1.13 |
| EPS Basic Continuous Ops | -0.82 | -0.80 | -0.97 | -0.85 | -1.13 |
| EPS Diluted Total Ops | -0.82 | -0.80 | -0.97 | -0.85 | -1.13 |
| EPS Diluted Continuous Ops | -0.82 | -0.80 | -0.97 | -0.85 | -1.13 |
| EBITDA(a) | $-27,955 | $-22,792 | $-25,946 | $-21,858 | $-29,527 |